CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: High Dose Intravenous Ascorbic Acid in Severe Sepsis [Phase 2]
Summary
Phase 2 trial update on high-dose intravenous ascorbic acid in severe sepsis; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Christiana Care Health Services | Conditions: Sepsis | Phase 2 | Status: TERMINATED | Results posted: 2021-02-16